Taro Pharmaceutical Industries Ltd. (TARO)


NYSE - NYSE Real Time Price. Currency in USD
113.59-2.92 (-2.51%)
As of 1:54 PM EDT. Market open.
People also watch:
SCRILCIIPXLUTHRTEVA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open115.81
Prev Close116.51
Bid113.72 x 100
Ask113.99 x 100
Day's Range113.40 - 116.23
52wk Range113.40 - 157.99
1y Target EstN/A
Market Cap4.86B
P/E Ratio (ttm)8.87
Beta0.40
Volume79,129
Avg Vol (3m)246,442
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube8 days ago

    ETF’s with exposure to Taro Pharmaceutical Industries Ltd. : September 21, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETF’s with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Reuters18 days ago

    U.S. Justice Department subpoenas Taro over generic drug pricing

    Taro Pharmaceutical Industries Ltd and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed. The company, which is headquartered in Israel, said late on Friday it received subpoenas on Thursday from the U.S. Justice Department's Antitrust Division. The subpoenas seek documents related to "corporate and employee records, generic pharmaceutical products and pricing" and the company's "communications with competitors and others" related to the sale of generic products.

  • Capital Cube20 days ago

    ETF’s with exposure to Taro Pharmaceutical Industries Ltd. : September 9, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETF’s with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)